Shandong Xinhua Pharmaceutical Co Ltd – the country's largest manufacturer of antipyretic and analgesic drugs – recently started to supply phenobarbital tablets to the Venezuelan market, in what was said to be a milestone for the company's international development strategy based on the Belt and Road Initiative.
An exterior view of the International Cooperation Center operated by Shandong Xinhua Pharmaceutical Co Ltd, which is exporting its products to both Africa and South America. [Photo/zbnews.net]
The enterprise first exported phenobarbital tablets to Madagascar in November last year.
The tablets are the first controlled psychotropic drugs exported by the enterprise and the raw materials are also being produced by the company. The production, storage and circulation of the tablets have very strict control conditions and the successful development of the international market and commercial exports have involved a long process.
During it, the pharma group overcame various difficulties such as the outbreak of COVID-19, before finally realizing the first overseas shipment of phenobarbital tablets to Madagascar by the end of 2021.
The good international reputation, high-quality products, existing registration certificates and positive market feedback about the company has laid a solid foundation for opening up more international markets for phenobarbital tablets.
Xinhua Pharmaceutical has exported more than 7 million phenobarbital tablets since April. [Photo/zbnews.net]
The enterprise received an import license for the Venezuelan market in April and began commercial exports at once. While the product is still in the initial stage of its international market development, it has exported more than 7 million tablets in the past few months.
